筋強直性ジストロフィーtype 1における耐糖能障害

書誌事項

タイトル別名
  • Glucose intolerance in myotonic dystrophy type 1

抄録

Insulin resistance is a characteristic feature of glucose intolerance in myotonic dystrophy type 1 (DM1). DM1 patients with dysglycaemia have liver insulin resistance as well as muscle insulin resistance, and also abnormality of insulin secretion. Insulin resistance in DM1 might result in multiple metabolic defects. Low level of fasting plasma glucose is a characteristic feature in the early stage of glucose intolerance in DM1, Early intervention against insulin resistance in DM1 is suggested because glucose intolerance could deteriorate in a certain degree of cases. Metformin treatment is useful to improve insulin resistance in DM1. Diabetic patients with DM1 usually show mild hyperglycemia. However, poorly controlled patients with hyperglycemic pattern tending to rise from morning to evening exist. Intensive insulin therapy might be necessary in such cases. We should pay attention to hypoglycemia due to hyperinsulinemia, pseudo improvement of glucose control according to exacerbated dysphagia, and acute aggravation caused by infections, at a bedside.<br>

収録刊行物

  • 臨床神経学

    臨床神経学 52 (11), 1259-1260, 2012

    日本神経学会

参考文献 (3)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390001205035577856
  • NII論文ID
    130004505125
  • DOI
    10.5692/clinicalneurol.52.1259
  • ISSN
    18820654
    0009918X
  • PubMed
    23196582
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • Crossref
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ